Cargando…
Evaluation of (134)Ce/(134)La as a PET Imaging Theranostic Pair for (225)Ac α-Radiotherapeutics
(225)Ac-targeted α-radiotherapy is a promising approach to treating malignancies, including prostate cancer. However, α-emitting isotopes are difficult to image because of low administered activities and a low fraction of suitable γ-emissions. The in vivo generator (134)Ce/(134)La has been proposed...
Autores principales: | Bobba, Kondapa Naidu, Bidkar, Anil P., Meher, Niranjan, Fong, Cyril, Wadhwa, Anju, Dhrona, Suchi, Sorlin, Alex, Bidlingmaier, Scott, Shuere, Becka, He, Jiang, Wilson, David M., Liu, Bin, Seo, Youngho, VanBrocklin, Henry F., Flavell, Robert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315697/ https://www.ncbi.nlm.nih.gov/pubmed/37201957 http://dx.doi.org/10.2967/jnumed.122.265355 |
Ejemplares similares
-
Treatment of Prostate Cancer with CD46-targeted (225)Ac Alpha Particle Radioimmunotherapy
por: Bidkar, Anil P., et al.
Publicado: (2023) -
Prostate-Specific
Membrane Antigen Targeted Deep Tumor
Penetration of Polymer Nanocarriers
por: Meher, Niranjan, et al.
Publicado: (2022) -
PSMA-Targeted Nanotheranostics for Imaging and Radiotherapy of Prostate Cancer
por: Meher, Niranjan, et al.
Publicado: (2023) -
Beam allocation for S134
por: CERN. Geneva. Electronic Experiments Committee
Publicado: (1973) -
Covalent Proteins
as Targeted Radionuclide Therapies
Enhance Antitumor Effects
por: Klauser, Paul C., et al.
Publicado: (2023)